Auxiliary Discrminator Sequence Generative Adversarial Networks (ADSeqGAN) for Few Sample Molecule Generation

• URL: http://arxiv.org/abs/2502.16446v1
• Date: Sun, 23 Feb 2025 05:22:53 GMT
• Title: Auxiliary Discrminator Sequence Generative Adversarial Networks (ADSeqGAN) for Few Sample Molecule Generation
• Authors: Haocheng Tang, Jing Long, Junmei Wang,
• Abstract summary: Auxiliary Discriminator Sequence Generative Adversarial Networks (ADSeqGAN) is a novel approach for molecular generation in small-sample datasets.<n>Our method incorporates pretrained generator and Wasserstein distance to enhance training stability and diversity.<n>We have demonstrated the successful applications of ADSeqGAN in generating synthetic nucleic acid-targeting and CNS drugs.
• Score: 0.6339750087526286
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: In this work, we introduce Auxiliary Discriminator Sequence Generative Adversarial Networks (ADSeqGAN), a novel approach for molecular generation in small-sample datasets. Traditional generative models often struggle with limited training data, particularly in drug discovery, where molecular datasets for specific therapeutic targets, such as nucleic acids binders and central nervous system (CNS) drugs, are scarce. ADSeqGAN addresses this challenge by integrating an auxiliary random forest classifier as an additional discriminator into the GAN framework, significantly improves molecular generation quality and class specificity. Our method incorporates pretrained generator and Wasserstein distance to enhance training stability and diversity. We evaluate ADSeqGAN on a dataset comprising nucleic acid-targeting and protein-targeting small molecules, demonstrating its superior ability to generate nucleic acid binders compared to baseline models such as SeqGAN, ORGAN, and MolGPT. Through an oversampling strategy, ADSeqGAN also significantly improves CNS drug generation, achieving a higher yield than traditional de novo models. Critical assessments, including docking simulations and molecular property analysis, confirm that ADSeqGAN-generated molecules exhibit strong binding affinities, enhanced chemical diversity, and improved synthetic feasibility. Overall, ADSeqGAN presents a novel framework for generative molecular design in data-scarce scenarios, offering potential applications in computational drug discovery. We have demonstrated the successful applications of ADSeqGAN in generating synthetic nucleic acid-targeting and CNS drugs in this work.

Related papers

• A Reinforcement Learning-Driven Transformer GAN for Molecular Generation [6.397243531623856]
  This study introduces RL-MolGAN, a novel Transformer-based discrete GAN framework designed to address these challenges. Unlike traditional Transformer, RL-MolGAN utilizes a first-decoder-then-encoder structure, facilitating the generation of drug-like molecules from both $denovo$ and scaffold-based designs. In addition, RL-MolGAN integrates reinforcement learning (RL) and Monte Carlo tree search (MCTS) techniques to enhance the stability of GAN training and optimize the chemical properties of the generated molecules.
  arXiv  Detail & Related papers  (2025-03-17T04:06:10Z)
• UniGenX: Unified Generation of Sequence and Structure with Autoregressive Diffusion [61.690978792873196]
  Existing approaches rely on either autoregressive sequence models or diffusion models. We propose UniGenX, a unified framework that combines autoregressive next-token prediction with conditional diffusion models. We validate the effectiveness of UniGenX on material and small molecule generation tasks.
  arXiv  Detail & Related papers  (2025-03-09T16:43:07Z)
• Dumpling GNN: Hybrid GNN Enables Better ADC Payload Activity Prediction Based on Chemical Structure [53.76752789814785]
  DumplingGNN is a hybrid Graph Neural Network architecture specifically designed for predicting ADC payload activity based on chemical structure. We evaluate it on a comprehensive ADC payload dataset focusing on DNA Topoisomerase I inhibitors. It demonstrates exceptional accuracy (91.48%), sensitivity (95.08%), and specificity (97.54%) on our specialized ADC payload dataset.
  arXiv  Detail & Related papers  (2024-09-23T17:11:04Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• TAGMol: Target-Aware Gradient-guided Molecule Generation [19.977071499171903]
  3D generative models have shown significant promise in structure-based drug design (SBDD) We decouple the problem into molecular generation and property prediction. The latter synergistically guides the diffusion sampling process, facilitating guided diffusion and resulting in the creation of meaningful molecules with the desired properties. We call this guided molecular generation process as TAGMol.
  arXiv  Detail & Related papers  (2024-06-03T14:43:54Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• Latent Chemical Space Searching for Plug-in Multi-objective Molecule Generation [9.442146563809953]
  We develop a versatile 'plug-in' molecular generation model that incorporates objectives related to target affinity, drug-likeness, and synthesizability. We identify PSO-ENP as the optimal variant for multi-objective molecular generation and optimization.
  arXiv  Detail & Related papers  (2024-04-10T02:37:24Z)
• Molecular De Novo Design through Transformer-based Reinforcement Learning [38.803770968809225]
  We introduce a method to fine-tune a Transformer-based generative model for molecular de novo design. Our proposed method exhibits superior performance in generating compounds predicted to be active against various biological targets. Our approach can be used for scaffold hopping, library expansion starting from a single molecule, and generating compounds with high predicted activity against biological targets.
  arXiv  Detail & Related papers  (2023-10-09T02:51:01Z)
• Energy-based Generative Models for Target-specific Drug Discovery [7.509129971169722]
  We develop an energy-based probabilistic model for computational target-specific drug discovery. Results show that our proposed TagMol can generate molecules with similar binding affinity scores as real molecules.
  arXiv  Detail & Related papers  (2022-12-05T16:41:36Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.